End ‐stage renal disease patients using angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study

Internal Medicine Journal,Volume 48, Issue 9, Page 1123-1132, September 2018.

Source: Internal Medicine Journal - September 5, 2018 Category: Internal Medicine Authors: Hsin ‐Fu Lee , Lai‐Chu See , Yi‐Hsin Chan , Yung‐Hsin Yeh , Lung‐Sheng Wu , Jia‐Rou Liu , Hui‐Tzu Tu , Chun‐Li Wang , Chi‐Tai Kuo , Shang‐Hung Chang Source Type: research